Barry R. Zeebèrg

4.2k citations

83 papers · 3.2k indexed · 1 hit paper · h-index 21

Molecular Biology top 5%
Cell Biology top 5%
Oncology top 10%
Cellular and Molecular Neuroscience top 5%
Cancer Research top 10%

Co-authors: Michael Caplow John N. Weinstein David W. Kane William C. Reinhold Margot Sunshine Kimberly J. Bussey Joseph Riss J. Carl Barrett
Topics: Receptor Mechanisms and Signaling (22 papers)Neuroscience and Neuropharmacology Research (21 papers)Medical Imaging Techniques and Applications (16 papers)
Cited by: Molecular Biology Cell Biology Cancer Research
Journals: Journal of the American Chemical Society Journal of Biological Chemistry Nature Genetics
Partner nations: United States Russia Germany

In The Last Decade

Barry R. Zeebèrg

81 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

GoMiner: a resource for biological interpretation of genomic and proteomic data

2003 963 citations Barry R. Zeebèrg, Margot Sunshine et al. Genome biology profile →

Peers

Countries citing papers authored by Barry R. Zeebèrg

Since Specialization

Citations

This map shows the geographic impact of Barry R. Zeebèrg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry R. Zeebèrg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry R. Zeebèrg more than expected).

Fields of papers citing papers by Barry R. Zeebèrg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry R. Zeebèrg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry R. Zeebèrg. The network helps show where Barry R. Zeebèrg may publish in the future.

Co-authorship network of co-authors of Barry R. Zeebèrg

This figure shows the co-authorship network connecting the top 25 collaborators of Barry R. Zeebèrg. A scholar is included among the top collaborators of Barry R. Zeebèrg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry R. Zeebèrg. Barry R. Zeebèrg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Bioinformatics-Based Alternative mRNA Splicing Code that May Explain Some Disease Mutations Is Conserved in Animals 2017 ·Frontiers in Genetics ·(unknown),Pablo Cingolani,Barry R. Zeebèrg,Douglas M. Ruden	10
2	Transcription Poisoning by Topoisomerase I Is Controlled by Gene Length, Splice Sites, and miR-142-3p 2013 ·Cancer Research ·Stéphanie Solier,Michaël Ryan,Scott E. Martin,Sudhir Varma,Kurt W. Kohn,Hongfang Liu,Barry R. Zeebèrg,Yves Pommier	38
3	Concordance of Gene Expression and Functional Correlation Patterns across the NCI-60 Cell Lines and the Cancer Genome Atlas Glioblastoma Samples 2012 ·PLoS ONE ·Barry R. Zeebèrg,Kurt W. Kohn,A Kahn,Vladimir Larionov,John N. Weinstein,William C. Reinhold,Yves Pommier	14
4	RedundancyMiner: De-replication of redundant GO categories in microarray and proteomics analysis 2011 ·BMC Bioinformatics ·Barry R. Zeebèrg,Hongfang Liu,A Kahn,Martin Ehler,Vinodh N. Rajapakse,Robert F. Bonner,Jacob D. Brown,Brian P. Brooks,V. Larionov,William C. Reinhold,John N. Weinstein,Yves Pommier	18
5	Nonlinear gene cluster analysis with labeling for microarray gene expression data in organ development 2011 ·BMC Proceedings ·Martin Ehler,Vinodh N. Rajapakse,Barry R. Zeebèrg,Brian P. Brooks,Jacob D. Brown,Wojciech Czaja,Robert F. Bonner	8
6	Genome-wide Analysis of Novel Splice Variants Induced by Topoisomerase I Poisoning Shows Preferential Occurrence in Genes Encoding Splicing Factors 2010 ·Cancer Research ·Stéphanie Solier,Jennifer J. Barb,Barry R. Zeebèrg,Sudhir Varma,(unknown),Kurt W. Kohn,John N. Weinstein,Peter J. Munson,Yves Pommier	46
7	SpliceCenter: A suite of web-based bioinformatic applications for evaluating the impact of alternative splicing on RT-PCR, RNAi, microarray, and peptide-based studies 2008 ·BMC Bioinformatics ·Michaël Ryan,Barry R. Zeebèrg,Natasha J. Caplen,(unknown),A Kahn,Hongfang Liu,John N. Weinstein	32
8	VennMaster: Area-proportional Euler diagrams for functional GO analysis of microarrays 2008 ·BMC Bioinformatics ·Hans A. Kestler,André Frotta Müller,Johann M. Kraus,Malte Buchholz,Thomas M. Gress,Hongfang Liu,David W. Kane,Barry R. Zeebèrg,John N. Weinstein	83
9	SpliceMiner: a high-throughput database implementation of the NCBI Evidence Viewer for microarray splice variant analysis 2007 ·BMC Bioinformatics ·A Kahn,Michaël Ryan,Hongfang Liu,Barry R. Zeebèrg,D. Curtis Jamison,John N. Weinstein	20
10	The p53 Tumor Suppressor Network Is a Key Responder to Microenvironmental Components of Chronic Inflammatory Stress 2005 ·Cancer Research ·Frank Staib,Ana I. Robles,Lyuba Varticovski,Xin Wei Wang,Barry R. Zeebèrg,(unknown),Victor B. Zhurkin,Lorne J. Hofseth,S. Perwez Hussain,John N. Weinstein,Peter R. Galle,Curtis C. Harris	87
11	Nova regulates brain-specific splicing to shape the synapse 2005 ·Nature Genetics ·Jernej Ule,Aljaž Ule,Joanna L. Spencer-Segal,Alan J. Williams,(unknown),Melissa Cline,Hui Wang,Tyson A. Clark,Claire Fraser,Matteo Ruggiu,Barry R. Zeebèrg,David W. Kane,John N. Weinstein,John E. Blume,Robert B. Darnell	390
12	High-Throughput GoMiner, an 'industrial-strength' integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID) 2005 ·BMC Bioinformatics ·Barry R. Zeebèrg,Haiying Qin,(unknown),Margot Sunshine,(unknown),David W. Kane,Mark Reimers,Robert M. Stephens,David Bryant,Stanley K. Burt,Eldad Elnekave,Danielle M. Hari,Thomas A. Wynn,Charlotte Cunningham‐Rundles,Donn M. Stewart,David L. Nelson,John N. Weinstein	229
13	Analysis of ATP-Binding Cassette Transporter Expression in Drug-Selected Cell Lines by a Microarray Dedicated to Multidrug Resistance 2004 ·Molecular Pharmacology ·(unknown),Gergely Szakács,Charles J. Tucker,Angela Arciello,Carol Cardarelli,Jennifer Collins,Sherry F. Grissom,Barry R. Zeebèrg,William C. Reinhold,John N. Weinstein,Yves Pommier,Richard S. Paules,Michael M. Gottesman	69
14	MatchMiner: a tool for batch navigation among gene and gene product identifiers 2003 ·Genome biology ·Kimberly J. Bussey,David W. Kane,Margot Sunshine,(unknown),Satoshi Nishizuka,William C. Reinhold,Barry R. Zeebèrg,Ajay,John N. Weinstein	129
15	In vitro and in vivo m2 muscarinic subtype selectivity of some dibenzodiazepinones and pyridobenzodiazepinones 2000 ·Brain Research ·V. I. COHEN,(unknown),R McRee,(unknown),E. Cohen,(unknown),Barry R. Zeebèrg,Richard C. Reba	7
16	In Vivo Competition Studies of Z-(-,-)-[<sup>125</sup>I]IQNP Against 3-Quinuclidinyl 2-(5-Bromothienyl)- 2-Thienylglycolate (BrQNT) Demonstrating In Vivo m2 Muscarinic Subtype Selectivity for BrQNT 1998 ·Journal of Molecular Neuroscience ·V. I. COHEN,Barry R. Zeebèrg,(unknown),(unknown),(unknown),(unknown),D.W. McPherson,Richard C. Reba	12
17	Autoradiographic Evidence That 3-Quinuclidinyl-4-fluorobenzilate (FQNB) Displaysin VivoSelectivity for the m2 Subtype 1996 ·NeuroImage ·(unknown),(unknown),(unknown),V. I. COHEN,Barry R. Zeebèrg,Richard C. Reba	8
18	Resolution and in Vitro and Initial in Vivo Evaluation of Isomers of Iodine-125-Labeled 1-Azabicyclo[2.2.2]oct-3-yl .alpha.-Hydroxy-.alpha.-(1-iodo-1-propen-3-yl)-.alpha.-phenylacetate: A High-Affinity Ligand for the Muscarinic Receptor 1995 ·Journal of Medicinal Chemistry ·D.W. McPherson,(unknown),(unknown),(unknown),R McRee,Barry R. Zeebèrg,(unknown),Furn F. Knapp	23
19	Autoradiographic Evidence That QNB Displays in Vivo Selectivity for the m2 Subtype 1995 ·NeuroImage ·R McRee,(unknown),(unknown),E. Cohen,V. I. COHEN,(unknown),Barry R. Zeebèrg,R.E. Gibson,Richard C. Reba	14
20	3-D computer simulations of resolution effects of multidetector point focusing SPECT imaging 1991 ·IEEE Transactions on Medical Imaging ·(unknown),Barry R. Zeebèrg,Murray H. Loew,Richard C. Reba	2

About Barry R. Zeebèrg

Barry R. Zeebèrg is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 83 papers that have together received 3.2k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (22 papers), Neuroscience and Neuropharmacology Research (21 papers) and Medical Imaging Techniques and Applications (16 papers). The work is most often cited by research in Molecular Biology (2.4k citations), Cell Biology (459 citations) and Cancer Research (269 citations). Barry R. Zeebèrg has collaborated with scholars based in United States, Russia and Germany. Frequent co-authors include Michael Caplow, John N. Weinstein, David W. Kane, William C. Reinhold, Margot Sunshine, Kimberly J. Bussey, Joseph Riss, J. Carl Barrett, May D. Wang and Weimin Feng. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact